MedPath

Investigation of Heylo, a Novel App Driven Digital Supporting Ostomy Product

Not Applicable
Completed
Conditions
Ileostomy - Stoma
Colostomy Stoma
Interventions
Device: Heylo
Device: Standard of Care
Registration Number
NCT05200416
Lead Sponsor
Coloplast A/S
Brief Summary

People with intestinal stomas can have, despite development of better ostomy products, problems with leakage which influence their quality of life negatively.

To overcome this, Coloplast has developed a new supporting ostomy product called Heylo™, which has an adhesive sensor layer that should be placed underneath the baseplate. The sensor layer consists of an electronic sensor system that continuously detects moisture and output leakage underneath the baseplate. A transmitter connected to the sensor layer continuously evaluates the incoming information and sends a status to a smartphone software application, which based on a predefined flow decides which information to deliver to the user about the baseplate status.

The overall aim of this clinical investigation is to evaluate the benefits of the new supporting product, Heylo compared to Standard of Care.

Detailed Description

The Investigational device - Heylo, is already CE-marked.

The investigation is an open-labelled, randomized cross-over trial with two test periods evaluating Heylo and Standard of Care.

In total 144 subjects having an ileostomy or an colostomy will be included and randomized.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
144
Inclusion Criteria
  • Has given written consent to participate by signing the Informed Consent Signature Form.
  • Is at least 18 years of age and has full legal capacity.
  • Has an ileostomy or colostomy with consistent liquid/mushy fecal output (5-7 Bristol scale*)
  • Is able to use one of the five test products (i.e. Ø40, Ø50, Ø60, Ø70, Ø80 mm).
  • Has experienced leakage** under the baseplate at least three times within the last fourteen days. **Leakage defined as output seeping under the baseplate"
  • Has worry about leakage to "some degree, high degree, or very high degree" (on a five-point Likert scale: Very low degree/Not at all, Low degree, some degree, High degree, very high degree)
  • Is willing to refrain from use of ostomy paste.
  • Has a smartphone compatible with the Heylo™ application
  • Is able to follow study procedures for 4 months (assessed by investigator or delegate)
Exclusion Criteria
  • Is participating in other clinical investigations or has previously participated in this investigation
  • Is pregnant or breastfeeding
  • Has known hypersensitivity towards any of the products used in the investigation
  • Is using/ has a pacemaker

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Test Product - HeyloStandard of CareThe arm includes the test product Heylo
Test Product - HeyloHeyloThe arm includes the test product Heylo
Standard of CareHeyloThe arm includes Standard of Care
Standard of CareStandard of CareThe arm includes Standard of Care
Primary Outcome Measures
NameTimeMethod
Emotional Impact Score (Scale From 0-100)8 weeks

Measured by the validated OLI scale evaluated at the end of each test period. The questionnaire regarding Emotional impact contains 10 questions where the 4 answer options are: All of the time, Often, Sometimes and Rarely or never, which can be converted into a combined numerical score. The scale ranges from 0-100, where a score of 100 equals no impact and a score of 0 represents full impact.

Secondary Outcome Measures
NameTimeMethod
Participation in Society Domain Score (Scale From 0-100)8 weeks

Measured by WHODAS 2.0 evaluated at the end of each test period. The questionnaire regarding Participation in society contains 11 questions where the 5 answer options are: None, Mild, Moderate, Severe and Extreme or cannot do, which can be converted into a combined domain score. Each domain has a range of 0-100, where low scores equal better health and high scores indicate greater disability.

Trial Locations

Locations (1)

Peter C. Ambe

🇩🇪

Bergisch Gladbach, Bergisch Gladbach,Nordrhein-Westfalen, Germany

© Copyright 2025. All Rights Reserved by MedPath